资讯

Ohtuvayre (ensifentrine), a drug approved in 2024 to treat chronic obstructive pulmonary disorder (COPD), is receiving high marks from doctors and patients. Ohtuvayre is the first new inhaled COPD ...
Discover what bronchial spasms are, including their causes, symptoms, and effective remedies. Learn how to manage and prevent ...
Poor treatment of asthma and COPD puts a huge burden on the NHS. For example, £1 billion is spent on asthma treatment in the UK each year and represents 60,000 to 65,000 hospital admissions.
belief that Ohtuvayre's bronchodilator and non-steroidal anti-inflammatory activity can re-define the COPD treatment paradigm." The encouraging sales figures come at a time when treatment options ...
Asthma and COPD share similar symptoms. Understanding the differences and similarities between the two conditions is important for effective diagnosis and treatment. Asthma and COPD both affect ...
This growth is primarily driven by the recent entry of biologics into the treatment landscape and an increasing focus on precision medicine. A major catalyst in the COPD market has been the US ...
GSK plc announced that the European Medicines Agency (EMA) has accepted for review its application to expand the use of Nucala (mepolizumab), a monoclonal antibody that targets interleukin-5 (IL-5), ...
Apr. 23, 2025 — A new study finds vision loss fears may deter some patients from cataract surgery, despite it being the only effective treatment. The research underscores the role of doctor ...
In acute infective exacerbation of chronic bronchitis or chronic obstructive pulmonary disease (COPD), adding erdosteine to standard treatment significantly modified the outcome by improving the ...
New phase 2 data for amlitelimab show efficacy in heterogeneous inflammatory asthma Lunsekimig now targeting chronic rhinosinusitis and COPD in addition to asthma Itepekimab expanding ... for this ...
COPD Risk Confirmed: Exclusive e-cigarette use is significantly associated with new cases of chronic obstructive pulmonary disease. Hypertension Warning: A modest increase in high blood pressure ...